The Top 15 Broker Darlings of the Dow: Current Top Analyst Picks
By The Online Investor Staff, updated Thu., Apr. 25, 6:27 AM
| This Slide: #1 of 15 |
#15 of the Dow 30: Pfizer Inc (NYSE:PFE)
Pfizer is a research-based biopharmaceutical company. Co.'s portfolio includes medicines and vaccines, as well as consumer healthcare products. Co. manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Co.'s health business units (except Consumer Healthcare) as well as a hospital business unit that commercializes its portfolio of sterile injectable and anti-infective medicines; Upjohn, which includes Co.'s solid oral dose brands such as Lyrica, Lipitor, Norvasc, Viagra and Celebrex, as well as certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business.
Pfizer SEC Filing Email Alerts Service
Open the PFE Page at The Online Investor »
|
||||||||||||||||||||||||
Open the PFE Page at The Online Investor (in a new window) »
PFE Average Broker Rec.
 
|
 Buy (3.11 out of 4) 45th percentile
(ranked lower than approx. 55% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
|
|
| Avg. Broker Rec.
|
Buy (3.11 out of 4) 45th percentile
(ranked lower than approx. 55% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
